Aduhelm Market 2026–2035 evolving with Alzheimer’s treatment demand

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Aduhelm Market By 2030 Starting From Its 2026 Size?

Historical growth has been driven by several factors, including an increasingly elderly global demographic, the absence of effective treatments for Alzheimer’s disease, significant progress in amyloid research, the growing occurrence of dementia, and an escalation in neurological clinical trials.

The projected growth during the forecast period can be attributed to an expanding population of Alzheimer’s patients, an increasing demand for early intervention therapies, the broadening scope of biomarker-based diagnosis, enhanced healthcare spending on neurology, and the development of next-generation monoclonal antibodies. Simultaneously, significant trends anticipated in this period include a heightened focus on disease-modifying Alzheimer’s therapies, the rising application of monoclonal antibodies in neurology, increased investment in neurodegenerative research, a strong emphasis on early Alzheimer’s diagnosis, and the expansion of treatments targeting amyloid.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19857&type=smp

What Primary Drivers Are Shaping The Development Of The Aduhelm Market?

The increasing prevalence of Alzheimer’s disease is anticipated to propel the growth of the Aduhelm market going forward. Alzheimer’s disease is a progressive neurodegenerative disorder characterized by a decline in cognitive functions like memory, reasoning, and behavior. The rise in Alzheimer’s prevalence is attributed to several interconnected demographic, medical, and societal factors. Aduhelm (aducanumab-avwa) is employed to treat Alzheimer’s disease by targeting and reducing amyloid-beta plaques in the brain, which are believed to contribute to the disease’s progression. For example, in May 2024, the Alzheimer Society, a UK-based organization assisting individuals affected by dementia, reported that an estimated 982,000 people in the UK currently live with dementia, a figure projected to increase to 1.4 million by 2040. Therefore, the increasing prevalence of Alzheimer’s disease is a significant driver for the growth of the Aduhelm market.

Which Segment Categories Define The Aduhelm Market?

The aduhelm market covered in this report is segmented –

1) By Indication: Mild Cognitive Impairment, Mild Dementia

2) By Distribution Channel: Hospitals And Clinics, Retail And Specialty Pharmacies

3) By End User: Adult, Geriatric

What Major Market Trends Are Driving Changes In The Aduhelm Market?

Companies operating in the Aduhelm market are prioritizing the development of innovative products, such as self-injectable monoclonal antibody formulations, to enhance patient convenience and adherence. These self-injectable formulations empower patients to administer their maintenance doses independently using a prefilled pen or syringe, thereby reducing their reliance on hospital infusions. For example, in 2025, Eisai and Biogen, a US- and Japan-based biopharmaceutical collaboration specializing in neurological therapies and antibody-based medicines, launched Leqembi Iqik (lecanemab self-injectable pen). Its main characteristics include a patient-friendly prefilled pen designed for at-home administration, a dosing regimen tailored for maintenance therapy, safety and tolerability data comparable to the IV version, and a design intended to minimize needle anxiety for users.

Who Are The Top Companies Competing In The Aduhelm Market?

Major companies operating in the aduhelm market are Biogen Inc., Eisai Co. Ltd.

Read the full aduhelm market report here:

https://www.thebusinessresearchcompany.com/report/aduhelm-global-market-report

How Does The Aduhelm Market Perform Across Major Global Regions?

North America was the largest region in the aduhelm market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aduhelm market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Aduhelm Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19857&type=smp

Browse Through More Reports Similar to the Global Aduhelm Market 2026, By The Business Research Company

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Adtech Market Report 2026

https://www.thebusinessresearchcompany.com/report/adtech-global-market-report

Print Advertising Distribution Market Report 2026

https://www.thebusinessresearchcompany.com/report/print-advertising-distribution-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795